TrialBMC pulmonary medicine2020

Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.

Nobuyoshi Hamao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.